TC
NGM

Trium Capital’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Trium Capital’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-977,965
Closed -$1.55M – 103
2024
Q1 		$1.55M Buy
+977,965
New +$1.45M 0.58% 38

Trium Capital's NGM Position: Q2 2024 in Review

Trium Capital sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 977,965 shares — an estimated $1.55M sold.

Trium Capital first reported a position in NGM in Q1 2024 and held it in 1 quarter. The position peaked at $1.55M in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • Trium Capital reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Trium Capital sold 977,965 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.55M.
  • Trium Capital first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Trium Capital's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.55M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Trium Capital's 13F filing for Q2 2024, filed 6 Aug 2024.